Sources | Names Used |
---|---|
CTRPv2 | alisertib:navitoclax (2:1 mol/mol) |
PharmacoGx | alisertib:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DPM1 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
mRNA | AHNAK | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-06 |
mRNA | NBPF10 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
mRNA | NFS1 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
mRNA | TRPV2 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0001 |
mRNA | RAB1A | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
mRNA | SLC12A4 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |
mRNA | ASAP2 | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-05 |
mRNA | SYDE1 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0002 |
mRNA | ARHGAP12 | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-05 |